Showing results (1081-1090 of 4,514) with videos related to

Sort By:
Pageof 452
Future Oncology (London, England)|September 25, 2024
Real-world safety and effectiveness of lenvatinib in unresectable hepatocellular carcinoma in Korea: post-marketing studyWonseok Kang, Yoon Jun Kim, Seung Up Kim, et al.
Future Oncology (London, England)|September 17, 2024
A plain language summary of the PERSEUS study of daratumumab plus bortezomib, lenalidomide, and dexamethasone for treating newly diagnosed multiple myelomaPieter Sonneveld, Meletios A Dimopoulos, Mario Boccadoro, et al.
Future Oncology (London, England)|September 17, 2024
MANEUVER: A Phase III study of pimicotinib to assess efficacy and safety in tenosynovial giant cell tumor patientsXiaohui Niu, Vinod Ravi, Boyao Shan, et al.
Future Oncology (London, England)|May 30, 2023
TROPION-Lung08: phase III study of datopotamab deruxtecan plus pembrolizumab as first-line therapy for advanced NSCLCBenjamin P Levy, Enriqueta Felip, Martin Reck, et al.
Future Oncology (London, England)|March 13, 2026
The integrated 31-gene expression profile test identifies low-risk patients with cutaneous melanoma who can forego the SLNB procedure: results from a prospective, multicenter trialTimothy Beard, J Michael Guenther, Stanley P Leong, et al.
Future Oncology (London, England)|November 8, 2024
The pivotal role of autophagy in the pathogenesis and therapy of medulloblastomaSeidu A Richard
Future Oncology (London, England)|November 12, 2024
Patients' and clinicians' knowledge in cancer-related cognitive impairment and its implications: current perspectiveMaria Vittoria Ferrari, Lorenzo Conti, Benedetta Capetti, et al.
Future Oncology (London, England)|November 7, 2024
Understanding how CD19 expression levels impact the response to loncastuximab tesirine: a plain language summaryPaolo F Caimi, Mehdi Hamadani, Carmelo Carlo-Stella, et al.
Future Oncology (London, England)|November 8, 2024
Sitravatinib in patients with solid tumors selected by molecular alterations: results from a Phase Ib studyLyudmila Bazhenova, Dong-Wan Kim, Byoung Chul Cho, et al.
Future Oncology (London, England)|October 28, 2024
First-line sunitinib treatment modification in patients with mRCC: nationwide analysis of the Swedish populationMaria Jakobsson, Fredrik Nilsson, Angela Strambi, et al.
Pageof 452